121 related articles for article (PubMed ID: 2733040)
1. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.
Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE
J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040
[TBL] [Abstract][Full Text] [Related]
2. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease.
Bain C; Colditz GA; Willett WC; Stampfer MJ; Green A; Bronstein BR; Mihm MC; Rosner B; Hennekens CH; Speizer FE
Am J Epidemiol; 1988 Apr; 127(4):703-12. PubMed ID: 3354537
[TBL] [Abstract][Full Text] [Related]
3. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
Tsao H; Bevona C; Goggins W; Quinn T
Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
5. Frequency of moles as a key to melanoma incidence?
Rampen FH; van der Meeren HL; Boezeman JB
J Am Acad Dermatol; 1986 Dec; 15(6):1200-3. PubMed ID: 3492519
[TBL] [Abstract][Full Text] [Related]
6. Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice.
Little P; Keefe M; White J
BMJ; 1995 Apr; 310(6984):912-6. PubMed ID: 7719184
[TBL] [Abstract][Full Text] [Related]
7. Frequency of moles in a defined population.
Cooke KR; Spears GF; Skegg DC
J Epidemiol Community Health; 1985 Mar; 39(1):48-52. PubMed ID: 3989434
[TBL] [Abstract][Full Text] [Related]
8. Which pigmented moles should be removed in prepubertal-age children? A case for a conservative approach.
Keipert JA
Med J Aust; 1984 Oct; 141(8):518-20. PubMed ID: 6482800
[TBL] [Abstract][Full Text] [Related]
9. Incidence and evolution of moles and the relationship to malignant melanoma in eastern India.
Reddy CR; Yellama A; Satyanarayana BV; Sundareshwar B
Int Surg; 1976 Sep; 61(9):469-71. PubMed ID: 965185
[TBL] [Abstract][Full Text] [Related]
10. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
Rieger E; Soyer HP; Garbe C; Büttner P; Kofler R; Weiss J; Stocker U; Krüger S; Roser M; Weckbecker J
Int J Cancer; 1995 Aug; 62(4):393-7. PubMed ID: 7635564
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for melanoma by body site.
Cho E; Rosner BA; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1241-4. PubMed ID: 15894679
[TBL] [Abstract][Full Text] [Related]
12. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
Olsen CM; Zens MS; Stukel TA; Sacerdote C; Chang YM; Armstrong BK; Bataille V; Berwick M; Elwood JM; Holly EA; Kirkpatrick C; Mack T; Bishop JN; Østerlind A; Swerdlow AJ; Zanetti R; Green AC; Karagas MR; Whiteman DC
Int J Cancer; 2009 Feb; 124(4):937-44. PubMed ID: 19035450
[TBL] [Abstract][Full Text] [Related]
13. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
14. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site.
Osterlind A; Engholm G; Jensen OM
APMIS; 1988 Nov; 96(11):953-63. PubMed ID: 3196476
[TBL] [Abstract][Full Text] [Related]
15. Incidence of benign pigmented moles (melanocytic naevi) in black Africans: divergent distribution with malignant melanoma.
Otu AA
Trop Doct; 1990 Oct; 20(4):179-80. PubMed ID: 2284678
[No Abstract] [Full Text] [Related]
16. Freckles, moles, melanoma and the ozone layer: a tale of the relationship between humans and their environment.
Marks R
Med J Aust; 1989 Dec 4-18; 151(11-12):611-3. PubMed ID: 2593903
[No Abstract] [Full Text] [Related]
17. Reliability of interviewer and subject assessments of nevus counts in a study of melanoma.
Walter SD; Marrett LD; Hertzman C
J Clin Epidemiol; 1991; 44(7):633-40. PubMed ID: 2066743
[TBL] [Abstract][Full Text] [Related]
18. Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma.
Wei EX; Li X; Nan H
J Am Acad Dermatol; 2019 Apr; 80(4):970-978. PubMed ID: 30713015
[TBL] [Abstract][Full Text] [Related]
19. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
Clark WH; Reimer RR; Greene M; Ainsworth AM; Mastrangelo MJ
Arch Dermatol; 1978 May; 114(5):732-8. PubMed ID: 646394
[TBL] [Abstract][Full Text] [Related]
20. Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.
Li X; Kraft P; De Vivo I; Giovannucci E; Liang L; Nan H
J Am Acad Dermatol; 2020 Oct; 83(4):1049-1056. PubMed ID: 32376423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
